Cumming School of Medicine
Synergy between pro-inflammatory cytokines and glucocorticoid on TLR2 expression: Mechanisms and consequences in pulmonary epithelial cells
Abstract
dc:description.abstractGlucocorticoids are effective in controlling mild-to-moderate asthma due to their profound anti-inflammatory properties. Acting via the glucocorticoid receptor (GR), glucocorticoids repress the expression of numerous inflammatory genes to ultimately dampen airway inflammation. Prior dogma suggests that ligand-activated GR may interact directly with inflammatory transcription factors at target gene loci to downregulate gene expression. However, glucocorticoids also inactivate mitogen-activated protein kinase (MAPK) pathways to reduce the expression of numerous inflammatory genes. Despite this, the repression of inflammatory gene expression is not an invariable outcome of glucocorticoid action. In this thesis, synergy occurring between synthetic glucocorticoids and pro-inflammatory cytokines on the expression of toll-like receptor 2 (TLR2), and its consequences, is explored in pulmonary epithelial cells. Mechanistically, the transcription factors, NF-?B and GR, were revealed as necessary for inducing TLR2 expression by IL1B plus glucocorticoid. Similarly, STAT1, along with NF-?B and GR, was involved in the upregulation of TLR2 expression by IL1B plus IFNG plus glucocorticoid. Thus, functional interactions between GR and inflammatory transcription factors, such as, NF-?B and STAT, can cooperatively increase gene transcription. In addition, p38 MAPK was shown to negatively regulate IL1B-induced TLR2 expression. Thus, glucocorticoid inhibition of p38 activity releases this negative regulation to enhance TLR2 expression in the context of IL1B plus glucocorticoid. This represents a mechanism by which glucocorticoids maintain, even enhance, the expression of genes that are negatively regulated by MAPKs. Agonism of glucocorticoid plus cytokine-induced TLR2 in A549 cells revealed enhanced and sensitized interferon response factor 1 (IRF1)-dependent responses, maintained NF-?B-dependent responses, albeit to a lower extent, coupled with the release of multiple cytokines and chemokines. Thus, expression of TLR2 induced by inflammatory cytokines plus glucocorticoids results in pro-inflammatory effects and is predicted to promote inflammatory cell recruitment. Overall, the transcriptional regulation of TLR2 illustrates distinct mechanisms that allow differential regulation of inflammatory gene expression by glucocorticoids. While the ability of glucocorticoids to promote TLR2-mediated effects may be a part of normal host defense, such effects may be undesirable in conditions, such as severe asthma or during viral exacerbations. Such pro-inflammatory effects that are resultant from enhanced TLR2 expression may contribute to glucocorticoid insensitivity.
Degree
thesis:*- Name thesis:degree_name
- Doctor of Philosophy (PhD)
- Discipline thesis:degree_discipline
- Medicine – Cardiovascular/Respiratory Science
- Grantor
- Cumming School of Medicine
- Year dc:date.issued
- 2022
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Bansal, Akanksha
- Advisor dc:contributor.advisor
-
- Newton, Robert
- Committee members dc:contributor.committeemember
-
- Marle, Guido van
- Yipp, Bryan G
Subjects
dc:subject × 3Rights
- Language dc:language.iso
- English
Identifiers
dc:identifier.*- Dc Identifier Citation
- Bansal, A. (2022). Synergy between pro-inflammatory cytokines and glucocorticoid on TLR2 expression: Mechanisms and consequences in pulmonary epithelial cells (Doctoral thesis). University of Calgary, Calgary, Canada). Retrieved from https://prism.ucalgary.ca .